Two researchers won the Nobel Prize in Chemistry on Wednesday for a gene-editing device that has transformed science by offering a way to modify DNA, which is deemed as the code of life — the tool is already being used in an attempt to heal a swarm of diseases and nurture better crops and livestock.
About Nobel winners
Emmanuelle Charpentier from France and Jennifer A. Doudna from the United States secured the prestigious prize for curating CRISPR-cas9, a very basic method for cutting a gene at a particular spot, letting scientists manage the flaws that are the primary origin of many diseases.
“There is enormous power in this genetic tool,” said Claes Gustafsson, head of the Nobel Committee for Chemistry.
Over 100 clinical trials are in the process to study with the help of CRISPR to cure inherited diseases, and “many are very promising,” as per Victor Dzau, president of the National Academy of Medicine.
“My greatest hope is that it’s used for good, to uncover new mysteries in biology and to benefit humankind,” said Doudna, who is associated with the University of California, Berkeley, and is remunerated by the Howard Hughes Medical Institute, which also backs The Associated Press’ Health and Science Department.
Nobel-winning Research’s consequences
The triumphant work has widened the avenues to some tricky virtuous issues: When editing is done after birth, the modifications are restricted to that person. Scientists dread that CRISPR will be abused to make “designer babies” by shifting eggs, sperm or embryos — alterations that can be conceded on to coming generations.
Dr. George Daley, dean of Harvard Medical School, stated: “New technology often presents this dichotomy — there is immense potential for human benefit, especially for disease treatment, but also the risk of misapplication.”
Nevertheless, scientists across the globe applauded the great prospects that gene editing has for people lately.
This is the fourth time in the record of the past 119 years of the prizes that a Nobel in the sciences was bestowed upon solely to women.
The revolutionary research completed by Charpentier and Doudna was circulated in 2012, making the finding very latest in relation to many other Nobel-winning researches, which is often respected only after years have conceded.